Imaging Mass Cytometry Grant Challenge – Call for abstracts!
We’d love to hear how you could use Imaging Mass Cytometry™ (IMC™) in your research, leveraging the Immuno-oncology IMC panel.
Submit an abstract describing your research project utilizing Imaging Mass Cytometry technology by June 21.
The selected project will be awarded a 50% discount on the study performed with the new immuno-oncology panel.
Take advantage of the opportunity to analyze your samples using the Immuno-oncology IMC panel. Quickly interpret the tumor microenvironment with modular IMC panels – enabling you to visualize tumor and immune interactions, map localized functional responses and characterize cell features. Hyperion™ XTi imaging workflows together with the Human Immuno-Oncology IMC Panel offer a powerful tool for investigating and understanding the intricacies of the TME, establishing the new standard for evaluating spatial biology.

Please submit your abstract here.
"*" indicates required fields
Terms and conditions
Publication of Project Results: All grant submissions are confidential to the individual submitter and will not be published or distributed, provided, however, that Standard BioTools may share them with their own staff and distributors who will not disclose to a third party. Applications will be reviewed by representatives of Standard BioTools. Upon project completion, the grant winner agrees to participate in at least one of the following activities relating to the specific project, with specific details of the applicable activity to be mutually agreed upon in good faith by Standard BioTools and the winner: webinar, case study, blog post, presentation, or poster presentation. The winner agrees that Standard BioTools shall have the right to publicly announce the winner’s name and research title and use anonymized data from the winner’s projects in application notes including in marketing materials and seminars. No public display of data will happen without previous written consent from the winner.
Eligibility and Requirements:
· Applicants must be actively enrolled or employed at a research institution in a capacity in which they perform life science research and have the ability to ship stained samples within 90 days of award notification.
· Members of the immediate families of Standard BioTools employees and directors, including the members of the panel of judges selecting the winners, and/or persons living in the same household as such persons, are ineligible to participate in this grant program.
· Applicants must not be government employees or a healthcare professionals. Employees of government institutions and healthcare professionals should not be eligible to participate in the program. A healthcare professional is anyone who is: authorized or licensed to provide healthcare services to patients; involved in providing healthcare services to patients (for example, clinical laboratory directors); or involved in the decision to purchase, prescribe, order, or recommend medical technologies or related services.
· This program is void where prohibited or otherwise restricted by law.
· The selected project will be awarded a 50% discount on the study performed with the Human Immuno-Oncology IMC Panel.
Miscellaneous: All grant applicants agree that Standard BioTools may process the personal data he or she provides as part of application, only for the needs of the application and grant competition process, and in accordance with the Standard BioTools Privacy Policy available at www.standardbio.com/legal/privacy.
The grant award winner may be required to sign and return an affidavit of eligibility, release of liability, a publicity release, and other appropriate legal documentation reasonably requested by Standard BioTools. No substitution or transfer of the awarded prize is allowed except as permitted by Standard BioTools. The award winner is responsible for any local tax liability (city, state, or federal) occurred by winning and accepting the award. If, for any reason, the grant program may not run as planned for any causes beyond the reasonable control of Standard BioTools, then Standard BioTools reserves the right in its sole discretion to cancel, terminate, modify, or suspend the grant program. These terms and conditions and any action related to this grant program will be governed by the laws of the State of California, U.S.A, without regard to or application of its conflict of law provisions or your state or country of residence. All claims, legal proceedings, or litigation arising in connection with these terms and conditions and this grant program will be brought solely in the federal or state courts located in San Francisco, State of California, U.S.A., and all applicants consent to the jurisdiction of and venue in such courts and waive any objection as to inconvenient forum. By participating in this grant program, each applicant unconditionally accepts and agrees to comply with and abide by these terms and conditions.
DISCLAIMERS. ANY ITEMS PROVIDED BY STANDARD BIOTOOLS TO THE GRANT WINNERS ARE DELIVERED TO THE WINNERS “AS IS,” WITHOUT WARRANTY OF ANY KIND, NATURE OR DESCRIPTION, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION, WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Without limiting the generality of the preceding sentence, unless otherwise expressly stated in writing by Standard BioTools, no claim or representation is made or intended: (i) as to any clinical use of any product provided herein (whether diagnostic, prognostic, therapeutic, blood banking, or any other clinical use); (ii) that any product provided herein has been cleared, approved, registered, or otherwise qualified by Standard BioTools with any regulatory agency for use in any clinical procedure or for other use requiring compliance with any federal, state, provincial, European, or any other governmental agency or regulatory body regulating diagnostic, therapeutic, blood, or other clinical products, medical devices or similar products; (iii) that any product provided herein will satisfy the requirements of any governmental body or other organization, including but not limited to the United States Food and Drug Administration or the International Organization for Standardization; or (iv) that any product provided herein or its performance is suitable or has been validated for any specific use or application.
LIABILITY. Standard BioTools cannot be held liable for any damage caused to the grant applicants or grant winners as a consequence of the implementation of the grant competition, or relating to the items provided by Standard BioTools to the grant winners, except when provided otherwise by mandatory applicable law.
